Johnson & Johnson stock gains 1.02% to EUR 244.48 premarket
Published on 11/20/2026 at 07:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSJohnson & Johnson At A Glance
- Johnson & Johnson focuses on healthcare innovation, including treatments for complex diseases and less invasive solutions.
- The company says more than 75% of sales come from products holding a number-one or number-two global market-share position.
- Johnson & Johnson reports more than 60 consecutive years of dividend increases.
Johnson & Johnson stock traded at EUR 244.48 on Lang & Schwarz at 07:49 CET on Friday, November 20, 2026, 1.02% above the Xetra close of Thursday, November 19, at EUR 242.00.
Johnson & Johnson focuses on healthcare innovation spanning medicines, treatments and solutions for complex diseases. The company's investor relations site says more than 75% of sales come from products with a number-one or number-two global market-share position.
For broader market context, see the S&P 500.
Disclaimer...
en | US4781601046 | JOHNSON & JOHNSON | boerse | 70538852 | bgmi
